Close Menu
  • Home
  • Life Insurance
  • Auto Insurance
  • Home Insurance
  • Health Insurance
  • Business Insurance
  • Travel Insurance
  • Specialized Insurance
  • Insurance Tips & Guides
Facebook X (Twitter) Instagram
Insure GenZInsure GenZ Friday, February 27
  • About Us
  • Contact Us
  • Disclaimer
  • Terms & Conditions
  • Privacy Policy
Facebook X (Twitter) Instagram
Subscribe
  • Home
  • Life Insurance
  • Auto Insurance
  • Home Insurance
  • Health Insurance
  • Business Insurance
  • Travel Insurance
  • Specialized Insurance
  • Insurance Tips & Guides
Insure GenZInsure GenZ
Home»Health Insurance»What About the State of Health?
Health Insurance

What About the State of Health?

AwaisBy AwaisFebruary 26, 2026No Comments3 Mins Read0 Views
Facebook Twitter Pinterest Telegram LinkedIn Tumblr Copy Link Email
Follow Us
Google News Flipboard
The Hazards of ICE for Public Health
Share
Facebook Twitter LinkedIn Pinterest Email Copy Link

The Host

After urging Republicans earlier this year to make health care a central issue in their midterm campaigns, President Donald Trump gave the issue only passing mention in his record-long State of the Union address this week.

Meanwhile, Trump’s nominee to become U.S. surgeon general, Casey Means, a favorite of the “Make America Healthy Again” movement, got her long-delayed hearing before a Senate committee this week. Means’ nomination has been controversial not only because of her outside-the-mainstream medical views but also because she would be the first surgeon general without an active medical license.

This week’s panelists are Julie Rovner of KFF Health News, Alice Miranda Ollstein of Politico, Sheryl Gay Stolberg of The New York Times, and Lauren Weber of The Washington Post.

Among the takeaways from this week’s episode:

  • Trump devoted little of the State of the Union to health care, even though affordability is top of mind for voters. The topics he did address, briefly, included lowering drug prices — an effort that has yielded some benefit for some people — and, notably, fraud. The next day, the administration announced it would withhold Medicaid funding for Minnesota over fraud allegations. While fraud is a serious, persistent problem for Medicaid, which covers those who are low-income and disabled, withholding federal funds from a single, Democratic-led state is a major step that puts other states on edge.
  • Means, Trump’s nominee for surgeon general, on Wednesday appeared before senators to make her case for confirmation. A central figure in the MAHA movement, Means was smooth and gracious in her presentation, yet there were worrying signs for public health — she declined to endorse the seasonal flu vaccine, for instance. She also faces questions about her medical credentials, a key qualification in particular for someone who would serve as the head of the Public Health Service Commissioned Corps.
  • The issue of abortion access was downplayed in Trump’s State of the Union and Means’ nomination hearing, reinforcing how times have changed since the first Trump administration — and raising questions about whether voters who strongly oppose abortion will be motivated to turn out for the midterm elections. Instead, Trump discussed fertility drugs during his speech, and Means expressed what she said are her concerns about the risks of oral contraceptives.

Email Sign-Up

Subscribe to KFF Health News’ free Morning Briefing.

Plus, for “extra credit” the panelists suggest health policy stories they read (or wrote) this week that they think you should read, too:

Julie Rovner: KFF Health News’ “When It Comes to Health Insurance, Federal Dollars Support More Than ACA Plans,” by Julie Appleby.  

Sheryl Gay Stolberg: ProPublica’s “South Carolina Hospitals Aren’t Required To Disclose Measles-Related Admissions. That Leaves Doctors in the Dark,” by Jennifer Berry Hawes.  

Lauren Weber: The Washington Post’s “Inside RFK Jr.’s Push Against the Flu Vaccine That He Links to His Voice Condition,” by Lauren Weber, Lena H. Sun, and Caitlin Gilbert.  

Alice Miranda Ollstein: Stat’s “Pharma Lobbyists Focus on a Surprising New Target: The FDA,” by Daniel Payne and Lizzy Lawrence.  

Also mentioned in this week’s podcast:


Click here to find all our podcasts.

And subscribe to “What the Health? From KFF Health News” on Apple Podcasts, Spotify, the NPR app, YouTube, Pocket Casts, or wherever you listen to podcasts.

Related Topics

Contact Us

Submit a Story Tip

Health state
Follow on Google News Follow on Flipboard
Share. Facebook Twitter Pinterest LinkedIn Telegram Email Copy Link
Awais
  • Website

Related Posts

Medicare Alternative Payment Models Support Improved Primary Care

February 26, 2026

Teladoc projects lower integrated care membership amid ACA subsidy lapse

February 26, 2026

How AI Can Both Detect and Enable Fraudulent Research – The Monitor

February 26, 2026
Leave A Reply Cancel Reply

Our Latest Blogs

Photon Re cat bond a ‘natural evolution’ of Lumen Re’s risk-transfer strategy: CUO Sapelza

February 27, 2026

Why Relationships Still Win in Small Business Insurance

February 26, 2026

What About the State of Health?

February 26, 2026

Financial results round-up: AMERISAFE, Safety Insurance, TWFG, Root, HCI

February 26, 2026
Recent Posts
  • Photon Re cat bond a ‘natural evolution’ of Lumen Re’s risk-transfer strategy: CUO Sapelza
  • Why Relationships Still Win in Small Business Insurance
  • What About the State of Health?
  • Financial results round-up: AMERISAFE, Safety Insurance, TWFG, Root, HCI
  • Tokio Marine America CEO eyes capital surge as growth engine

Subscribe to Updates

Insure Genz is a modern insurance blog built for the next generation. Subscribe it for more updates.

Insure Genz is a modern insurance blog built for the next generation. We break down complex topics across categories like Auto, Health, Business, Life, and Travel Insurance — making them simple, useful, and easy to understand. Whether you're just getting started or looking for expert tips and guides, we've got you covered with clear, reliable content.

Our Picks

Photon Re cat bond a ‘natural evolution’ of Lumen Re’s risk-transfer strategy: CUO Sapelza

February 27, 2026

Why Relationships Still Win in Small Business Insurance

February 26, 2026

What About the State of Health?

February 26, 2026

Financial results round-up: AMERISAFE, Safety Insurance, TWFG, Root, HCI

February 26, 2026
Most Popular

Photon Re cat bond a ‘natural evolution’ of Lumen Re’s risk-transfer strategy: CUO Sapelza

February 27, 2026

Why Relationships Still Win in Small Business Insurance

February 26, 2026

What About the State of Health?

February 26, 2026

Financial results round-up: AMERISAFE, Safety Insurance, TWFG, Root, HCI

February 26, 2026
  • About Us
  • Contact Us
  • Disclaimer
  • Terms & Conditions
  • Privacy Policy
© 2026 Insure GenZ. Designed by Insure GenZ.

Type above and press Enter to search. Press Esc to cancel.